Skip to Main Content

Latest News

New Drugs for an Elusive Cancer Target

Cancer Today spoke with Roy S. Herbst, a medical oncologist and lung cancer expert at Yale Cancer Center and Smilow Cancer Hospital in New Haven, Connecticut, about KRAS inhibitors and their potential for treating patients with cancer.

Read more